Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from AstraZeneca

AstraZeneca shares tumble after reports China unit is linked to insurance fraud

Pharmaceutical’s weight loss pill described as ‘underwhelming’, also piling pressure on share price

The Guardian - UK

AstraZeneca drags on FTSE as Wall Street positive amid US election voting

The FTSE 100 finished 11.85 points, or 0.14%, lower to end the day at 8,172.39.

Evening Standard

OBR moving to ‘trust but verify’ relationship with Treasury after ‘black hole’ row – as it happened

Rolling coverage of the latest economic and financial news

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat

Viking Therapeutics reported strong weight loss for higher doses of its experimental obesity drug.

Investors Business Daily

US economic growth slows, as Germany avoids recession and France gets Olympics boost – as it happened

Eurozone GDP grew by 0.4% in the last quarter, faster than expected, as Germany’s economy avoids second contraction in a row

The Guardian - UK

AstraZeneca ‘said it could cut UK jobs’ if biodiversity drug levy is introduced

Biotech giant’s alleged comments come as world leaders at Cop16 discuss how to share benefits from genetic code discoveries fairly

The Guardian - UK

‘The UK is at the back of the race of turtles’: Sanofi’s boss on the need to develop new medicines

Paul Hudson, the Briton in charge of the French drug firm, is a big believer in the potential of AI to transform healthcare

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

One of science’s greatest achievements: how the rapid development of COVID vaccines prepares us for future pandemics

Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 million deaths from the disease. This makes COVID the seventh-deadliest pandemic in recorded history.

The Conversation

As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer

Viking Therapeutics stock is on the rise as the battle to develop new weight-loss drugs heats up. Here's what's at stake for the pharma giants fighting for position.

Investors Business Daily

Boris Johnson considered invading Holland to seize Covid vaccines

The then prime minister convened a meeting of senior military officials to discuss the plans.

Evening Standard

Boris Johnson: we considered ‘aquatic raid’ on Netherlands to seize Covid vaccine

Former prime minister admits in extract from forthcoming book that he discussed possible aquatic operation at height of pandemic

The Guardian - UK

Nasal spray flu vaccine approved for home use: Here’s what to know

Vaccine provides an alternative to flu shots administered with needles

The Independent UK

AstraZeneca Stock Dips On Surprise Miss For Gilead-Rivaling Cancer Drug

AstraZeneca stock slumped Monday after its Daiichi Sankyo-partnered drug missed its mark in a study of patients with breast cancer.

Investors Business Daily

First Self-Administered Flu Vaccine For Home Use Gets FDA Approval

FluMist nasal spray manufactured by AstraZeneca is now approved for home use against influenza infection caused by subtypes A and B from ages 2 through 49.

Medical Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Salon

FDA clears at-home nasal flu vaccine

AstraZeneca’s FluMist can now be taken at home

The Conversation

Businesses that try to come clean about their impact on nature can end up concealing more than they reveal

Humans have overfished the ocean, cleared forests, polluted water and created a climate crisis by burning fossil fuels. These actions are affecting biodiversity around the world, from remote islands to our own backyards.

Fortune

Fortune LGBTQ+ Leaders

What will the LGBTQ+ Leaders of the future look like? Here are some of the names we expect to see a lot more of in the coming years.

The Independent UK

Man, 27, dies weeks after receiving Covid vaccine he was wrongly invited to take by NHS

Jack Last died after having the AstraZeneca Covid jab following a ‘litany’ of errors by GP services and the NHS

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analogue class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s not totally unprecedented in the history of pharmaceutical blockbusters.

The Guardian - UK

China detains five AstraZeneca staff over ‘data privacy and import breaches’

Detentions involve Chinese citizens who marketed cancer drugs for firm’s oncology division

Investors Business Daily

The 10 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race

The weight-loss drugs market could be worth up to $144 billion within six years. And a bevy of pharma stocks could get a lift.

The Guardian - UK

Britain could be a sci-tech superpower – if the Treasury stopped holding it back

The UK has the research base, the startups, the venture capitalists, but its presence in the global market is pitiful. The chancellor must step in

International Business Times

Big Pharma Push Back On First Medicare Drug Price Cuts

Major pharmaceutical companies lashed out following a landmark deal unveiled Thursday to cut the costs of 10 key medicines, with some saying the price-setting process was not transparent.

Salon

Big Pharma fought to keep prices high

Big Pharma exploited patent laws to stifle competition amid Medicare price negotiations, according to a new report

Investors Business Daily

Medicare Slashes Merck, Novo, AstraZeneca Drug Prices Up To 79% In IRA Negotiations

Diabetes treatments from Merck, Novo Nordisk and AstraZeneca will face the steepest cuts under the IRA, a list showed Thursday.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.